BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,529 | +1047.5% | 130 | +1344.4% | 0.00% | – |
| Q2 2023 | $569 | +40.5% | 9 | 0.0% | 0.00% | – |
| Q1 2023 | $405 | – | 9 | +50.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 6 | -71.4% | 0.00% | – |
| Q1 2022 | $1,000 | -93.8% | 21 | -85.8% | 0.00% | -100.0% |
| Q4 2021 | $16,000 | +6.7% | 148 | -1.3% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | +650.0% | 150 | +614.3% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 21 | -34.4% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 32 | +52.4% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 21 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 21 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 21 | -38.2% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 34 | +54.5% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | +100.0% | 22 | +37.5% | 0.00% | – |
| Q2 2018 | $1,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |